查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842394

全球荷爾蒙補充療法市場：市場規模、佔有率和趨勢分析（按產品、給藥途徑、疾病類型和地區分類），細分市場預測（2025-2033 年）

Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product, (HGH Replacement Therapy), By Route of Administration, By Disease Type, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

荷爾蒙補充療法市場摘要

全球荷爾蒙補充療法市場預計在 2024 年達到 235.8 億美元，預計到 2033 年將達到 394.2 億美元，2025 年至 2033 年的複合年成長率為 5.8%。

由於激素紊亂症的盛行率不斷上升，尤其是在老年族群中，荷爾蒙補充療法產業正在蓬勃發展。

與更年期相關的症狀，例如潮熱、盜汗、陰道乾澀和骨質疏鬆，推動了對有效治療方法的需求。例如，2024年10月，StatPearls Publishing報告了一項名為「停經後雌激素/黃體素干預試驗」的研究，該研究納入了875名使用荷爾蒙替代療法（HRT）來控制中度至重度血管舒縮症狀的女性。研究發現，與安慰劑組相比，僅使用雌激素組（OR=0.42；95% CI：0.28-0.62）和雌激素加黃體素組（OR=0.38；95% CI：0.25-0.58）的症狀均顯著減輕。雖然這項研究強調了HRT在緩解症狀方面的重要性，但也揭示了其在預防慢性疾病方面作用有限。男性性腺功能低下症症的日益普及以及預期壽命的延長，進一步推動了市場對HRT的接受度。

牛津皇家全科醫師學會研究與監測中心的一項研究分析了來自465家全科診所的180萬份醫療記錄，結果顯示，在接受雌激素類激素替代療法（HRT）的5451名女性中，新冠病毒感染率和死亡率降低了78%。人們對更年期、性腺功能減退和生長激素缺乏等疾病的認知不斷提高，使得患者群體日益擴大。製藥公司正在推出創新治療方法以滿足市場需求。例如，2022年1月，Ascendis Pharma A/S公司的SKYTROFA獲得了歐盟委員會的核准，這是第一個用於治療兒童生長激素缺乏症的每週一次的療法，與每日注射相比，該療法具有更高的依從性和便利性。

市場成長進一步受到人們對荷爾蒙缺乏症和罕見疾病認知提高的推動。總部位於英國的兒童生長基金會等機構為患者、看護者和醫療保健提供者提供教育、指導和支持，從而促進荷爾蒙替代療法（HRT）的普及。儘管發展勢頭強勁，但高昂的治療費用在某些地區仍然是一大障礙。注射型HRT的年費用，用戶為288美元至1440美元，無保險用戶為480美元至4800美元，限制了其可及性。然而，患者意識的提高、創新的藥物傳遞方法以及治療應用的不斷拓展，預計將持續推動荷爾蒙補充療法產業的長期成長。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章荷爾蒙補充療法市場：影響因素、趨勢和範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL 分析
    • 管道分析
    • 專利到期分析
    • 定價分析

第4章荷爾蒙補充療法市場：按產品分類的業務分析

  • 按產品分類的市場佔有率（2024 年和 2033 年）
  • 產品儀錶板
  • 按產品分類的市場規模預測和趨勢分析（2021-2033）
  • 雌激素-黃體素替代療法
  • 生長激素替代療法
  • 甲狀腺荷爾蒙補充療法
  • 睾酮替代療法
  • 副甲狀腺素替代療法

第5章荷爾蒙補充療法市場：按給藥途徑分類的業務分析

  • 按給藥途徑分類的市場佔有率（2024 年和 2033 年）
  • 管理路線儀錶板
  • 按給藥途徑分類的市場規模預測和趨勢分析（2021-2033）
  • 口服
  • 腸外
  • 經皮
  • 其他

第6章荷爾蒙補充療法市場：依疾病類型分類的商業分析

  • 按疾病類型分類的市場佔有率（2024 年和 2033 年）
  • 疾病類型儀錶板
  • 按疾病類型分類的市場規模預測和趨勢分析（2021-2033 年）
  • 閉經
  • 甲狀腺機能低下症
  • 男性性腺功能低下症
  • 生長激素缺乏症
  • 甲狀旁腺功能低下症

第7章荷爾蒙補充療法市場：區域估算與趨勢分析

  • 按地區分類的市場佔有率分析（2024 年和 2033 年）
  • 市場概覽：按地區
  • 市場規模預測及趨勢分析（2021-2033）
  • 北美洲
    • 按國家/地區分類（2021-2033 年）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與企業概況
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • Eli Lilly and Company
    • Bayer AG
    • Noven Pharmaceuticals, Inc.
    • Pfizer Inc.
    • Merck &Co., Inc.
    • Viatris, Inc.
    • Novo Nordisk A/S
    • F. Hoffmann-La Roche Ltd.
    • ASCEND Therapeutics US, LLC.
    • AbbVie, Inc.
Product Code: 978-1-68038-784-1

Hormone Replacement Therapy Market Summary

The global hormone replacement therapy market size was estimated at USD 23.58 billion in 2024 and is projected to reach USD 39.42 billion by 2033, growing at a CAGR of 5.8% from 2025 to 2033. The hormone replacement therapy industry is gaining momentum due to the rising prevalence of hormonal disorders, especially among aging populations.

Menopause-related conditions such as hot flashes, night sweats, vaginal dryness, and osteoporosis are fueling demand for effective therapies. For instance, October 2024, StatPearls Publishing reported that HRT was used to manage moderate-to-severe vasomotor symptoms, with the Postmenopausal Estrogen/Progestin Interventions trial of 875 women showing significant symptom reduction in estrogen-alone (OR, 0.42; 95% CI, 0.28-0.62) and estrogen-plus-progestin groups (OR, 0.38; 95% CI, 0.25-0.58) compared to placebo. The study clarified HRT's limited role in chronic disease prevention while highlighting its importance in symptom relief. Growing awareness of male hypogonadism, coupled with rising life expectancy, further expands market adoption.

A study by the Oxford-Royal College of General Practitioners Research and Surveillance Centre, analyzing 1.8 million medical records from 465 general practices, reported that 5,451 women on estrogen-based HRT experienced a 78% reduction in COVID-19 infection and mortality rates. Rising awareness of conditions such as menopause, hypogonadism, and growth hormone deficiency is expanding the patient base. Pharmaceutical companies are introducing innovative therapies to meet demand. For example, in January 2022, Ascendis Pharma A/S received European Commission approval for SKYTROFA, the first once-weekly treatment for pediatric growth hormone deficiency, offering improved adherence and convenience compared to daily injections.

Market growth is further supported by increasing awareness of hormone deficiencies and rare disorders. Organizations like the UK-based Child Growth Foundation provide education, guidance, and support to patients, caregivers, and healthcare providers, enhancing adoption of HRT. Despite this momentum, high treatment costs remain a barrier in certain regions. Annual injectable HRT costs range from USD 288 to USD 1,440 for insured patients and USD 480 to USD 4,800 for uninsured individuals, limiting accessibility. Nevertheless, rising patient awareness, innovative drug delivery methods, and expanded therapeutic applications are expected to sustain long-term growth in the hormone replacement therapy industry.

Global Hormone Replacement Therapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hormone replacement therapy market report based on product, route of administration, disease type, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Estrogen & Progesterone Replacement Therapy
  • HGH Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Testosterone Replacement Therapy
  • Parathyroid Hormone Replacement
  • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Parenteral
  • Transdermal
  • Others
  • Disease Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Hypoparathyroidism
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Route of Administration
    • 1.2.3. Disease Type
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hormone Replacement Therapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Hormone Replacement Therapy Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Estrogen & Progesterone Replacement Therapy
    • 4.4.1. Estrogen & Progesterone Replacement Therapy Market, 2021 - 2033 (USD Million)
  • 4.5. HGH Replacement Therapy
    • 4.5.1. HGH Replacement Therapy Market, 2021 - 2033 (USD Million)
  • 4.6. Thyroid Hormone Replacement Therapy
    • 4.6.1. Thyroid Hormone Replacement Therapy Market, 2021 - 2033 (USD Million)
  • 4.7. Testosterone Replacement Therapy
    • 4.7.1. Testosterone Replacement Therapy Market, 2021 - 2033 (USD Million)
  • 4.8. Parathyroid Hormone Replacement
    • 4.8.1. Parathyroid Hormone Replacement Market, 2021 - 2033 (USD Million)

Chapter 5. Hormone Replacement Therapy Market: Route of Administration Business Analysis

  • 5.1. Route of Administration Market Share, 2024 & 2033
  • 5.2. Route of Administration Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Route of administration, 2021 to 2033 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market, 2021 - 2033 (USD Million)
  • 5.5. Parenteral
    • 5.5.1. Parenteral Market, 2021 - 2033 (USD Million)
  • 5.6. Transdermal
    • 5.6.1. Transdermal Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Hormone Replacement Therapy Market: Disease Type Business Analysis

  • 6.1. Disease Type Market Share, 2024 & 2033
  • 6.2. Disease Type Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Disease type, 2021 to 2033 (USD Million)
  • 6.4. Menopause
    • 6.4.1. Menopause Market, 2021 - 2033 (USD Million)
  • 6.5. Hypothyroidism
    • 6.5.1. Hypothyroidism Market, 2021 - 2033 (USD Million)
  • 6.6. Male Hypogonadism
    • 6.6.1. Male Hypogonadism Market, 2021 - 2033 (USD Million)
  • 6.7. Growth Hormone Deficiency
    • 6.7.1. Growth Hormone Deficiency Market, 2021 - 2033 (USD Million)
  • 6.8. Hypoparathyroidism
    • 6.8.1. Hypoparathyroidism Market, 2021 - 2033 (USD Million)

Chapter 7. Hormone Replacement Therapy Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Hormone Replacement Therapy Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. Canada Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. UK Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Brazil Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. Argentina Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Hormone Replacement Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Eli Lilly and Company
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Bayer AG
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Noven Pharmaceuticals, Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Pfizer Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Merck & Co., Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Viatris, Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Novo Nordisk A/S
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. F. Hoffmann-La Roche Ltd.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. ASCEND Therapeutics US, LLC.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. AbbVie, Inc.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global hormone replacement therapy market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 6 Global hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 7 North America hormone replacement therapy market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 10 North America hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 11 U.S. hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 12 U.S. hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 13 U.S. hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 14 Canada hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 15 Canada hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 16 Canada hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 17 Mexico hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 18 Mexico hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 19 Mexico hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 20 Europe hormone replacement therapy market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 22 Europe hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 23 Europe hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 24 UK hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 25 UK hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 26 UK hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 27 Germany hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 28 Germany hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 29 Germany hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 30 France hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 31 France hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 32 France hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 33 Italy hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 34 Italy hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 35 Italy hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 36 Spain hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 37 Spain hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 38 Spain hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 39 Norway hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 40 Norway hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 41 Norway hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 42 Denmark hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 43 Denmark hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 44 Denmark hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 45 Sweden hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 46 Sweden hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 47 Sweden hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific hormone replacement therapy market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific hormone replacement therapy market, by product, 2021 - 2033 (USD
  • Table 50 Asia Pacific hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 52 Japan hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 53 Japan hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 54 Japan hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 55 China hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 56 China hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 57 China hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 58 India hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 59 India hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 60 India hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 61 Australia hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 62 Australia hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 63 Australia hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 64 South Korea hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 65 South Korea hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 66 South Korea hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 67 Thailand hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 68 Thailand hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 69 Thailand hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 70 Latin America hormone replacement therapy market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 72 Latin America hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 73 Latin America hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 74 Brazil hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 75 Brazil hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 76 Brazil hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 77 Argentina hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 78 Argentina hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 79 Argentina hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa hormone replacement therapy market, by country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 84 South Africa hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 85 South Africa hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 86 South Africa hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 90 UAE hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 91 UAE hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 92 UAE hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)
  • Table 93 Kuwait hormone replacement therapy market, by product, 2021 - 2033 (USD Million)
  • Table 94 Kuwait hormone replacement therapy market, by route of administration, 2021 - 2033 (USD Million)
  • Table 95 Kuwait hormone replacement therapy market, by disease type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Hormone replacement therapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Hormone replacement therapy market dynamics
  • Fig. 12 Hormone replacement therapy market: Porter's five forces analysis
  • Fig. 13 Hormone replacement therapy market: PESTLE analysis
  • Fig. 14 Product market, 2021 - 2033 (USD Million)
  • Fig. 15 Estrogen & Progesterone Replacement Therapy market, 2021 - 2033 (USD Million)
  • Fig. 16 HGH Replacement Therapy market, 2021 - 2033 (USD Million)
  • Fig. 17 Thyroid Hormone Replacement Therapy market, 2021 - 2033 (USD Million)
  • Fig. 18 Testosterone Replacement Therapy market, 2021 - 2033 (USD Million)
  • Fig. 19 Parathyroid Hormone Replacement market, 2021 - 2033 (USD Million)
  • Fig. 20 Route of administration market, 2021 - 2033 (USD Million)
  • Fig. 21 Oral market, 2021 - 2033 (USD Million)
  • Fig. 22 Parenteral market, 2021 - 2033 (USD Million)
  • Fig. 23 Transdermal market, 2021 - 2033 (USD Million)
  • Fig. 24 Others market, 2021 - 2033 (USD Million)
  • Fig. 25 Disease Type market, 2021 - 2033 (USD Million)
  • Fig. 26 Menopause market, 2021 - 2033 (USD Million)
  • Fig. 27 Hypothyroidism market, 2021 - 2033 (USD Million)
  • Fig. 28 Male Hypogonadism market, 2021 - 2033 (USD Million)
  • Fig. 29 Growth Hormone Deficiency market, 2021 - 2033 (USD Million)
  • Fig. 30 Hypoparathyroidism market, 2021 - 2033 (USD Million)
  • Fig. 31 Hormone replacement therapy market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. country dynamics
  • Fig. 35 U.S. Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 36 Canada country dynamics
  • Fig. 37 Canada Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico country dynamics
  • Fig. 39 Mexico Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 40 Europe Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 41 UK country dynamics
  • Fig. 42 UK Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany country dynamics
  • Fig. 44 Germany Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 45 France country dynamics
  • Fig. 46 France Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 47 Italy country dynamics
  • Fig. 48 Italy Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain country dynamics
  • Fig. 50 Spain Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden country dynamics
  • Fig. 54 Sweden Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark country dynamics
  • Fig. 56 Denmark Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 58 Japan country dynamics
  • Fig. 59 Japan Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 60 China country dynamics
  • Fig. 61 China Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 62 India country dynamics
  • Fig. 63 India Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 64 Australia country dynamics
  • Fig. 65 Australia Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea country dynamics
  • Fig. 67 South Korea Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 68 Thailand country dynamics
  • Fig. 69 Thailand Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 70 Latin America Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 71 Brazil country dynamics
  • Fig. 72 Brazil Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 73 Argentina country dynamics
  • Fig. 74 Argentina Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 75 MEA Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa country dynamics
  • Fig. 77 South Africa Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia country dynamics
  • Fig. 79 Saudi Arabia Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 80 UAE country dynamics
  • Fig. 81 UAE Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 82 Kuwait country dynamics
  • Fig. 83 Kuwait Hormone replacement therapy market, 2021 - 2033 (USD Million)
  • Fig. 84 Company categorization
  • Fig. 85 Company market position analysis
  • Fig. 86 Strategic framework